Evaluation of laboratory values affecting mortality of end-stage renal disease patients: a competing risks approach

Rayka Malek1, Ahmadreza Baghestani2, Farin Rashid-Farokhi3

  • 1School of Population Health sciences, King's College London, London, UK.

BMC Nephrology
|July 18, 2023
PubMed

Insights

Male gender, high serum calcium, and high parathyroid hormone levels are linked to poorer survival for patients undergoing hemodialysis (HD). Addressing these factors may improve outcomes for chronic kidney disease (CKD) patients.

Area of Science:

  • Nephrology
  • Public Health
  • Biostatistics

Background:

  • Chronic Kidney Disease (CKD) is a growing global health concern.
  • End-Stage Renal Disease (ESRD) patients on hemodialysis (HD) face significant survival challenges.
  • Understanding factors influencing ESRD patient survival is crucial for improving care.

Purpose of the Study:

  • To investigate demographic and laboratory predictors of survival in Iranian ESRD patients on HD.
  • To evaluate the impact of specific parameters on mortality and kidney transplantation rates.
  • To apply advanced statistical modeling for survival analysis in a real-world clinical setting.

Main Methods:

  • A cohort of 109 patients receiving chronic HD in Iran (2014-2018) was analyzed.
  • A two-parameter Weibull distribution and Bayesian approach modeled time to death and kidney transplantation (competing risks).
  • Demographic data and serum levels of calcium and intact parathyroid hormone (iPTH) were assessed.

Main Results:

  • Male gender, serum calcium >9.5 mg/dL, and iPTH >150 pg/mL were significantly associated with increased mortality hazard.
  • The cumulative incidence of death surpassed transplantation after the first two years of HD.
  • 4-year cumulative incidence was 63.7% for death and 36.3% for transplantation.

Conclusions:

  • Male sex, hypercalcemia, and hypoparathyroidism are adverse prognostic factors in HD patients.
  • Correction of these laboratory abnormalities may enhance survival rates in the ESRD population.
  • This study highlights key modifiable factors for improving long-term outcomes in hemodialysis patients.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
226
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
183
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
43
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
36
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
122